Sex-based survival differences in patients with untreated advanced oesophageal squamous cell carcinoma receiving chemotherapy and immune checkpoint inhibitors: a meta-analysis
ESMO Gastrointestinal Oncology
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Cite
Get new articles on “Gastroenterology”
Subscriptions, keyword tracking and favourites — in the Articlium Telegram bot.
Open in Telegram
Citation
✕
ГОСТ
APA
MLA
BibTeX
Sex-based survival differences in patients with untreated advanced oesophageal squamous cell carcinoma receiving chemotherapy and immune checkpoint inhibitors: a meta-analysis. // ESMO Gastrointestinal Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2949819826000439?dgcid=rss_sd_all
Sex-based survival differences in patients with untreated advanced oesophageal squamous cell carcinoma receiving chemotherapy and immune checkpoint inhibitors: a meta-analysis. ESMO Gastrointestinal Oncology. https://www.sciencedirect.com/science/article/pii/S2949819826000439?dgcid=rss_sd_all
“Sex-based survival differences in patients with untreated advanced oesophageal squamous cell carcinoma receiving chemotherapy and immune checkpoint inhibitors: a meta-analysis.” ESMO Gastrointestinal Oncology.
@article{article44775,
title = {Sex-based survival differences in patients with untreated advanced oesophageal squamous cell carcinoma receiving chemotherapy and immune checkpoint inhibitors: a meta-analysis},
journal = {ESMO Gastrointestinal Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2949819826000439?dgcid=rss_sd_all}
}